|
TSPAN6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.222080E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.379300E-03 |
| Normal-vs-Stage2 |
6.998400E-02 |
| Normal-vs-Stage3 |
9.754800E-04 |
| Normal-vs-Stage4 |
2.28560000004041E-06 |
| Stage1-vs-Stage2 |
7.365200E-01 |
| Stage1-vs-Stage3 |
3.733400E-01 |
| Stage1-vs-Stage4 |
2.476500E-03 |
| Stage2-vs-Stage3 |
3.520000E-01 |
| Stage2-vs-Stage4 |
1.737640E-02 |
| Stage3-vs-Stage4 |
4.543600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.457700E-03 |
| Normal-vs-AfricanAmerican |
1.642220E-01 |
| Normal-vs-Asian |
5.084200E-03 |
| Caucasian-vs-AfricanAmerican |
6.833000E-01 |
| Caucasian-vs-Asian |
6.293200E-01 |
| AfricanAmerican-vs-Asian |
5.488400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.359000E-03 |
| Normal-vs-Female |
1.896520E-03 |
| Male-vs-Female |
7.643200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.643400E-03 |
| Normal-vs-Age(41-60Yrs) |
4.221300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.806810E-04 |
| Normal-vs-Age(81-100Yrs) |
5.789200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.052800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.743220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.785600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.453200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.326600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.802780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.504100E-03 |
| Classical-VS-Follicular |
7.94190000000805E-05 |
| Classical-VS-Other |
5.226400E-01 |
| Classical-VS-Normal |
3.632300E-02 |
| Tall-VS-Follicular |
6.381200E-01 |
| Tall-VS-Other |
2.269600E-01 |
| Tall-VS-Normal |
1.396690E-04 |
| Follicular-VS-Other |
6.643500E-02 |
| Follicular-VS-Normal |
4.95700000002763E-06 |
| Other-VS-Normal |
8.359400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.980140E-03 |
| Normal-vs-N1 |
1.232900E-04 |
| N0-vs-N1 |
2.051800E-01 |
|
|
